William J. Oetgen, Jr., M.D., M.B.A.
_______________________________________________________________________________
Business Address:
12070 Old Line Centre #100
Waldorf, MD 20602
(301) 843-5890
(301) 705-6927 (facsimile)
E-mail Addresses:
oetgenw@georgetown.edu
ottgin@aol.com
Cellular telephone:
301-535-2493
Home Address:
647 First Street
Alexandria, VA 22314
(703) 535-6770
(703) 535-1511 (facsimile)
_______________________________________________________________________________
Education
1969 - 1973
Saint Louis University
Doctor of Medicine, cum laude
1994 - 1996
Georgetown University
Master of Business Administration
1965 - 1969
Marquette University
Bachelor of Arts in Psychology
1997 - 2001
University of Maryland University College
Bachelor of Science in Accounting
Walter Reed Army Medical Center
1973 - 1974
1974 - 1975
1975 - 1977
1979 - 1981
Internship - Pediatrics
Residency - Pediatrics
Residency - Internal Medicine
Fellowship - Cardiovascular Diseases
Clinical Activities
1988 - present
Georgetown University Hospital
Member of Medical Staff
Department of Medicine, Division of Cardiology
1986 - 2000
Greater Southeast Community Hospital
Member of Medical Staff
Chief of Cardiology Service (1987-1992)
1988 - present
Fort Washington Hospital
Member of Medical Staff
Chief of Cardiology Service (1987-2003)
President-elect of Medical Staff (1999 – 2001)
1977 - 2004
Southern Maryland Hospital Center
Member of Medical Staff
William J. Oetgen, Jr., M.D., M.B.A.
Page 2
1986 - present
Private Practice of Cardiology and Internal Medicine
Sole Proprietor (1986 – 1997)
Member of Maryland HealthCare Associates, LLC (1996 – 2001)
Maryland HealthCare Associates, Staff Cardiologist 2001 - present
Administrative Activities
2006 – present
Member, Board of Directors
Integra Professional Services, Inc.
Cincinnati, Ohio
2005 – present
Member, Board of Directors
MedStar Health, Inc.
Columbia, Maryland
Member, Corporate Audit Committee (2006-8)
Vice Chairman, Corporate Executive Compensation Committee (2006-8)
Member, Corporate Finance Committee (2005-6)
Member, Corporate Quality and Professional Affairs Committee (2005-6; 2007-8)
2005 – present
Associate Cardiologist
Cardiocore, Inc.
Bethesda, Maryland
2002 – present
Senior Clinical Adviser
Georgetown University
M.D. - M.B.A. Program
1997 - 2000
Apollo Medical Management Corporation
Secretary-Treasurer
Chairman, Finance Committee, 1998 – 2000
Director of Quality Improvement 2003 - 2007
1996 - 2001
Maryland HealthCare Associates, LLC
Vice President
Founding Member, Board of Directors
Chairman, Benefits Committee 1996-1997
Staff Cardiologist
1994 - 1996
Greater Southeast Healthcare System
Vice Chairman, Founding Member, Board of Directors
Chairman, Credentials Committee
HealthGuard, LLC - Independent Practitioner Association
Greater Southeast Healthcare System - Physician Hospital Organization
1998 - 1999
2002 - 2004
Avicis, Inc. (formerly HealthScribe, Inc.)
Sterling, Virginia
Director, Chief Medical Officer
Member, Audit Committee
William J. Oetgen, Jr., M.D., M.B.A.
Page 3
Teaching Activities – Academic Appointments
1982 - present
Georgetown University School of Medicine
Clinical Associate Professor of Medicine (1995 – present)
Clinical Assistant Professor of Medicine (1982-1995)
1997 - present
Georgetown University McDonough School of Business
Professorial Lecturer in Management
1977 - 1986
Uniformed Services University of the Health Sciences
Associate Professor of Medicine (1985 – 1986)
Assistant Professor of Medicine (1979 – 1985)
Instructor in Medicine (1977 – 1979)
Philanthropic and Cultural Activities
2007 – present
Member, Cosmos Club of Washington
2006 – present
Liberty Row Homeowners’ Association
Chairman, Finance Committee
2000 – 2003
Member, Parents’ Council for the Dean
School of Medicine
Georgetown University
1993 - present
Cheryl Ruane Memorial Foundation, Inc.
President
1985 – present
Eugene P. Flannery Memorial Foundation
President
Research Activities
1999 – 2000
Propafenone in the prevention of symptomatic recurrences of atrial fibrillation.
1999 – 2000
Lansoprazole 30 mg QD versus omeprazole 20 mg QD for erosive esophagitis.
1999 - 1999
Development of an artificial neural network for mortality risk adjustment in the
Cooperative Cardiovascular Project.
1998 - 1998
Renal function survey after intravascular radiocontrast procedure.
1997 – 1998
Gatifloxacin versus ceftriaxone in community-acquired pneumonia requiring
hospitalization.
William J. Oetgen, Jr., M.D., M.B.A.
Page 4
1995 - 1996
Development of an artificial neural network in the noninvasive diagnosis of
coronary artery disease.
1983 – 1985
Diltiazem on mortality and reinfarction after myocardial infarction.
1981 – 1986
Amiodarone for significant ventricular arrhythmias.
1981 – 1983
Oral flecainide for significant ventricular arrhythmias.
1981 – 1982
Oral nifedipine for pulmonary vasospasm in progressive systemic sclerosis.
Consultant Activities
2002 – present
American College of Cardiology Disease Management Workgroup Member
2002 – 2004
American College of Cardiology Task Force to Develop a Cardiac Catheterization
Laboratory Continuous Quality Improvement Toolkit Task Force Member
2000 – 2001
Prince George’s County, Maryland Police Aviation Branch
Consultant in Aviation Medicine
1994 - present
Delmarva Foundation for Medical Care, Inc.
Associate Clinical Coordinator
Western Integrity Center, Consultant
1994 - 1996
Washington, D.C. Metropolitan Police Department Helicopter Branch
Consultant in Aviation Medicine
1993 – 1995
Patient Outcomes in Managed Care Settings
Williams & Wilkins
Baltimore, Maryland
Editorial Board Member
1986 - present
Armed Forces Institute of Pathology
Department of Legal Medicine
Consultant in Cardiology and Primary Care
Consultant to Department of Defense Patient Safety Program
Consultant to United States Public Health Service Quality Review Panel
Consultant to Department of Health and Human Services, Office of Inspector General
Consultant to Department of Justice, Public Safety Officer Benefit Program
1984 - 2000
Federal Aviation Administration
Consultant in Cardiology
Senior Airman Medical Examiner
Military Service
1969 – 1986
Active Duty - United States Army
William J. Oetgen, Jr., M.D., M.B.A.
Page 5
Second Lieutenant – Captain: Medical Service Corps 1969 - 1973
Captain – Colonel: Medical Corps 1973 – 1986
1986 - 1999
U.S. Army Reserve
Colonel: Medical Corps, Retired
1980 - 1986
U.S. Army Health Services Command, Fort Sam Houston, Texas
U.S. Army Aviation Center, Fort Rucker, Alabama
Consultant in Aviation Medicine - Cardiology
1981 - 1986
Walter Reed Army Medical Center
Assistant Chief, Cardiology Service
Medical Director, Coronary Care Unit
1977 - 1978
U.S. Army Medical Command Korea
121st Evacuation Hospital - Seoul
Internist
Aviation Medical Officer
Teaching Awards
1985
Outstanding Teaching Service Award
Advanced Cardiac Life Support Project
Montgomery County Chapter
American Heart Association
1983
Lieutenant General Claire L. Channault Award
Outstanding Medical Center Teacher
Walter Reed Army Medical Center
1983
Intern Class Outstanding Staff Teacher Award
Walter Reed Army Medical Center
1981
Outstanding Teacher Award
Department of Medicine
Walter Reed Army Medical Center
Honor Societies and Other Awards
2002
Georgetown University School of Medicine
Clinical Faculty Silver Vicennial Medal
1999 - 2000
Dean’s List
University of Maryland University College
William J. Oetgen, Jr., M.D., M.B.A.
Page 6
1981
Meritorious Service Medal
Outstanding Service as Staff Cardiologist
Walter Reed Army Medical Center
1978
Army Commendation Medal
Outstanding Service as Internist and Aviation Medical Officer
Republic of Korea
1977
Bailey K. Ashford Award
Outstanding Clinical Research by Graduating Resident
Walter Reed Army Medical Center
1975
Ogden C. Bruton Award
Outstanding Clinical Research in Pediatrics
Military Pediatrics Section
American Academy of Pediatrics
1973
Pediatrics Award
St. Louis University
1973
Mosby Book Award
St. Louis University
1972 - 1973
President, Class of l973
St. Louis University School of Medicine
1972
Alpha Omega Alpha
National Medical Honor Society
1969
Alpha Sigma Nu
National Jesuit Honor Society
Professional Societies
Fellow, American College of Physicians
Fellow, American College of Cardiology
Member, Government Relations Committee, 1992 – 1998
Member, Catheterization Laboratory Quality Toolkit Task Force, 2002 - 2004
Member, Disease Management Oversight Task Force, 2002 - 2005
Fellow, American Academy of Pediatrics
Member, American Medical Association
Member, Maryland Chapter of the American College of Cardiology
Member, Executive Council, 1993 - 1996
Editor, Newsletter, 1993 -1996
Member, American College of Physician Executives
William J. Oetgen, Jr., M.D., M.B.A.
Page 7
Medical Licenses
Missouri - l973 #35049 (inactive)
Maryland - l974 #Dl6l29
District of Columbia - l974 #7689
Medical Board Certifications
National Board of Medical Examiners - l974 #164210
American Board of Internal Medicine - l977 #60l50
American Board of Pediatrics - l978 #02l7l4
American Board of Internal Medicine-Cardiovascular Disease - l98l #60l50
Activities and Interests
Civilian Aviation Ratings
Commercial Pilot
Airplane Single Engine Land, Instrument
Airplane Multiengine Land (VFR)
Helicopter
Flight Instructor
Airplane Single Engine
Instrument Airplane
Helicopter
Ground Instructor
Advanced
Instrument
United States History
American Civil War
World War II
Sports
Golf
Running
Music
Guitar
5 String Banjo
Personal
Born October 2, 1947
Savannah, Georgia
1970
Married
Phyllis Pellegrini Oetgen, J.D., M.S.W.
Children
Matthew Evan Oetgen, M.D. (1973)
Susan Keane Oetgen, M.M. (1974)
Catherine Christoff Oetgen, J.D. (1977)
William J. Oetgen, Jr., M.D., M.B.A.
Page 8
Publications
Dehmer GJ, Hirshfeld JW, Oetgen WJ, Mitchell K, Simon AW, Elma MA, Kellett MA, Brindis
RG. CathKIT: Improving quality in the cardiac catheterization laboratory. J Amer Coll Cardiol
2004;43:895-9.
Oetgen WJ, Oetgen PM. A business case for patient safety. The Physician Executive
2003;29(5)39-42.
Kilborn MJ, Rathore SS, Gersh BJ, Oetgen WJ, Solomon AJ. Amiodarone and mortality among
elderly patients with acute myocardial infarction with atrial fibrillation. Am Heart J 2002
144(6):1095-101.
Rathore SS, Gersh BJ, Weinfurt KP, Oetgen WJ, Schulman KA, Solomon AJ. The role of
reperfusion therapy in paced patients with acute myocardial infarction. Am Heart J 2001;142:516-9.
Rathore SS, Weinfurt KP, Gersh BJ, Oetgen WJ, Schulman KA, Solomon AJ. Treatment of
patients presenting with myocardial infarction who present with a paced rhythm. Ann Intern Med
2001;134:644-51.
Berger AK, Breall JA, Gersh BJ, Johnson AE, Oetgen WJ, Marciniak TJ, Schulman KA. Effect of
diabetes mellitus and insulin use on survival following acute myocardial infarction in the elderly
(The Cooperative Cardiovascular Project). Amer J Cardiol 2001; 87:272-7.
Rathore SS, Gersh BJ, Berger BP, Weinfurt KP, Oetgen WJ, Schulman KA, Solomon AJ. Acute
myocardial infarction complicated by advanced heart block in the elderly: prevalence and
outcomes. Am Heart J 2001;141:47-54.
Sheifer SE, Rathore SS, Gersh BJ, Weinfurt KP, Oetgen WJ, Breall JA, Schulman KA. Time to
presentation with acute myocardial infarction in the elderly: association with race, sex, and
socioeconomic characteristics. Circulation 2000;102:1651-6.
Rathore SS, Berger AK, Weinfurt KP, Feinleib M, Oetgen WJ, Gersh, BJ, Schulman KA. Race,
sex, poverty and the medical treatment of acute myocardial infarction in the elderly. Circulation
2000; 102:642-8.
Thiemann DR, Coresh J, Schulman SP, Gerstenblith G, Oetgen WJ, Powe NR. Lack of benefit for
intravenous thrombolysis in myocardial-infarction patients more than 75 years old. Circulation
2000;101:2239-2246.
Rathore SS, Berger AK, Weinfurt KP, Oetgen WJ, Schulman KA, Gersh BJ, Solomon AJ. Acute
myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes.
Circulation 2000; 101: 969 – 974.
Oetgen ME, Flannery FT, Oetgen, WJ. The medico-legal implications of coronary ultrafast
computed tomography. Legal Medicine 99 1999; (1): 37- 41.
William J. Oetgen, Jr., M.D., M.B.A.
Page 9
Thiemann DR, Coresh J, Oetgen WJ, Powe NR: The effects of hospital volume, hospital
technology and physician specialty on long-term survival after acute myocardial infarction in the
elderly. N Eng J Med 1999;340:1640-8.
Berger AK, Edris DW, Breall JA, Oetgen WJ, Marciniak TA, Molinari GF: Resource use and
quality of care for Medicare patients with acute myocardial infarction in Maryland and the District
of Columbia: analysis of data from the Cooperative Cardiovascular Project. Am Heart J 1998;
135:349-56.
Oetgen ME, Dowd-Whittington J, Oetgen WJ, Flannery FT: Diet drug liability. Legal Medicine 98
1998;(1): 37-40.
Oetgen WJ, Molinari GF: The Health Care Quality Improvement Program and the Cooperative
Cardiovascular Project in Maryland. Maryland Medical Journal 1996; 45:853-4.
Itchhaporia D, Snow P, Almassy RJ, Oetgen WJ: Artificial neural networks: current status in
cardiovascular medical research. J Amer Coll Cardiol 1996; 28(2):515-21.
Oetgen WJ: Medical heuristics. Ann Intern Med 1996; 125(1): 77-78. (letter)
Oetgen WJ, Wiley MJ: Medical practice guidelines: Is cookbook medicine here? Legal Medicine
Open File 1996;23-6.
Oetgen WJ: Editorial comment: Heart failure: evaluation and care of patients with left-ventricular
systolic dysfunction. Patient Outcomes 1995;2(1):19-20.
Oetgen WJ: Editorial comment: Screening for asymptomatic coronary artery disease. Patient
Outcomes 1994;1(5):11.
Oetgen WJ: Editorial comment: Early management of patients with acute myocardial infarction.
Patient Outcomes 1993;1(November):38.
Oetgen WJ: Overview of AMA Directory's cardiovascular parameters. Managed Care 1993;2:60-l.
The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on
mortality and reinfarction after myocardial infarction. N Engl J Med 1992;327:669-77.
Fox, SM, Office of Motor Carriers - Federal Highway Administration. Conference on Cardiac
Disorders and Commercial Drivers. U.S. Department of Transportation FHWA-MC-88-40,
Washington DC, December 1987. (Steering Committee Member and Conference Participant)
Weston LT, Raybuck BD, Robinowitz M, Brinker JA, Oetgen WJ: Primary amyloid heart disease
presenting as hypertrophic obstructive cardiomyopathy. Cathet Cardiovasc Diagn 1986; 12(3):
l76-81.
Shuck JW, Walder J, Oetgen WJ, Thomas HM: Right ventricular visualization by Thallium-20l
myocardial scintigraphy in chronic obstructive pulmonary disease. Southern Med J 1985;78:l435-9.
William J. Oetgen, Jr., M.D., M.B.A.
Page 10
Oetgen WJ: Current concepts of aviation cardiology. U.S. Medicine pp 22-26, l Aug l985.
Oetgen WJ, Jones SL, Pettyjohn FS: Intracardiac electrophysiologic studies in the medical
evaluation of aviators. Aviat Space and Envir Med 1985;56:443-50.
Shuck JW, Oetgen WJ, Tesar JT: Pulmonary vascular response during Raynaud's phenomenon in
progressive systemic sclerosis. Amer J Med 1985;78:22l-7.
Wain HJ, Amen DG, Oetgen WJ: Hypnotic intervention and cardiac arrhythmias: advantages,
disadvantages, precautions and theoretical considerations. Am J Clin Hypnosis 1984;27:70-5.
Shuck JW, McCormick DJ, Cohen IS, Oetgen WJ, Brinker JA: Percutaneous balloon valvuloplasty
of the pulmonic valve: role of right to left shunting through a patent foramen ovale. J Amer Coll
Cardiol 1984;4:l32-5.
Oetgen, WJ, Sobol SM, Tri TB, Heydorn WH, Rakita L: Amiodarone-digoxin interaction: clinical
and experimental observations. Chest 1984; 86: 75-9.
Goldstein RE, Tibbits PA, Oetgen WJ: Proarrhythmic effects of antiarrhythmic drugs. In Clinical
Aspects of Life Threatening Arrhythmias: Annals of New York Academy of Science 1984;427:94l00.
Oetgen WJ, Tibbits PA, Abt MEO, Goldstein RE: Clinical and electrophysiologic assessment of
oral flecainide acetate for recurrent ventricular tachycardia: evidence for exacerbation of electrical
instability. Amer J Cardiol 1983;52:746-50.
Oetgen WJ, Galioto FM, Scott LP, Cardiac arrhythmias due to ventricular parasystole in a twelveyear old child. Southern Med J 1983;76:660-2.
Oetgen WJ, Perry LW, Shapiro SR, Galioto FM, Ruckman RN, Potter BM, Scott LP: Left
ventricular pseudotumor: a two-dimensional echocardiographic sign of aortic insufficiency.
Pediatric Cardiology 1983;4:37-40.
Oetgen WJ, Mutter ML, Lawless OJ, Davia JE: Cardiac abnormalities in mixed connective tissue
disease. Chest 1983;83:l85-8.
Oetgen WJ, Steinweg DL, Kimball DB: The hospital discharge summary: a new format. Mil Med
1982;147:l054-5.
Oetgen WJ, Umfrid RP, Hamilton KM, Rixse RS, Perry LW, Scott LP: Two-dimensional
echocardiography in the diagnosis of left atrial myxoma in a child. Southern Med J 75:1982;ll25-6.
Rajfer SI, Oetgen WJ, Weeks KD, Kaminski RJ, Rocchini AP: Thallium-20l scintigraphy after
surgical repair of hemodynamically significant primary coronary artery anomalies. Chest
1982;81:687-92.
Tibbits PA, Oetgen WJ, Potter BM, Chandra R, Avery GB, Perry LW, Scott LP: Interruption of
aortic arch masquerading as persistent fetal circulation with diagnosis by two-dimensional
echocardiography. Amer Heart J 1981;102:936-8.
William J. Oetgen, Jr., M.D., M.B.A.
Page 11
Oetgen WJ, Umfrid RP, Hamilton KM, Rixse RS, Perry LW, Scott LP: Left atrial myxoma. Am J
Dis Child 1981;135:579 (letter).
Oetgen WJ, Boice JA, Lawless OJ: Mixed connective tissue disease in children and adolescents.
Pediat 1981;67:333-7.
Brewer TG, Oetgen WJ, Dunn MA, Johnson LF: Hepatitis B in United States soldiers in Korea.
Southern Med J 1980;73:l568-9.
Landes RD, Bass JW, Milluncheck EW, Oetgen WJ: Neonatal rubella following postpartum
maternal immunization. J Pediat 1980;97:465-7.
Oetgen WJ: Chlamydial pneumonia vs. Wilson-Mikity syndrome. Pediat 1979;64:ll9-20 (letter).
Engler RJM, Oetgen WJ, Hyman LR: Congenital facial diplegia (Moebius Syndrome) and diabetes
insipidus: case report. Mil Med 1979;144:ll7-9.
Oetgen WJ: Chlamydia pneumonitis. N Engl J Med 1978;299:48 (letter).
Oetgen WJ, Landes RD: Aeromedical evacuation of high risk infants: experience at a military
medical center. Mil Med 1978;143:7l2-3.
Oetgen WJ, Bass JW: Mumps and hypoglycorrhachia. Pediat 1978;61:l58 (letter).
Oetgen WJ: Pertussiod eosinophilic pneumonia. Chest 1978; 73:120.
Oetgen WJ, Figelman AN: Treatment of diabetic ketoacidosis with continuous infusion of insulin. J
Pediat 1977;90:847-8 (letter).
Oetgen WJ: Pertussoid eosinophilic pneumonia. Chest 1977;71:492-6.
Oetgen WJ: The use of citrulline for the treatment of Reye's Syndrome: case reports. Mil Med 1977;
141:l62-4.
Oetgen WJ: Reye's Syndrome. American Society of Hospital Pharmacists - Voices 12/60 1976;6:5
(audiotape presentation).
Oetgen WJ, Shira JE, Hyman LR, Walker PF: Citrulline for Reye's Syndrome. N Engl J Med 1974;
291:42l (letter).
Oetgen WJ, Witzleben CL: Clinical practitioners as a resource for curriculum planning. J Med Educ
1973;48:949-5l.
Oetgen WJ, Pepper MP: Medical school admissions committee members: a descriptive study. J
Med Educ 1972;47:966-8.
William J. Oetgen, Jr., M.D., M.B.A.
Page 12
Abstracts Published
Rathore SS, Gersh BJ, Oetgen WJ, Solomon AJ. Prognostic significance of conduction disorders
complicating acute myocardial infarction in the elderly. J Amer Coll Cardiol 2001;37 (Supplement
A) 332A.
Rathore SS, Gersh BJ, Weinfurt KP, Oetgen WJ, Schulman KA, Solomon AJ. Effectiveness of
reperfusion therapy among elderly myocardial infarction patients presenting with left bundle branch
block. Circulation. 2000;102:II-385.
Rathore SS, Epstein AJ, Weinfurt KP, Berger AK, Oetgen WJ, Gersh BJ, Schulman KA. Hospital
characteristics and treatment of acute myocardial infarction: role of ownership and teaching status.
J Amer Coll Cardiol 2000; 35 (Supplement A) 267A.
Rathore SS, Weinfurt KP, Gersh BJ, Oetgen WJ, Schulman KA, Solomon AJ. Treatment of paced
patients with acute myocardial infarction. J Amer Coll Cardiol 2000; 35 (Supplement A) 143A.
Rathore SS, Weinfurt KP, Gersh BJ, Oetgen WJ, Schulman KA, Solomon AJ. Reperfusion therapy
among paced patients with acute myocardial infarction. J Amer Coll Cardiol 2000; 35 (Supplement
A) 396A.
Sheifer SE, Rathore SS, Gersh BJ, Weinfurt KP, Oetgen WJ, Breall JA, Schulman KA. Time to
presentation with acute myocardial infarction in the elderly: associations with race, gender and
poverty. Circulation 1999; 100 (Supplement I) I-805.
Rathore SF, Berger AK, Weinfurt KP, Feinleib M, Oetgen WJ, Gersh BJ, Schulman KA. Race,
gender, community socioeconomic characteristics and the medical treatment of acute myocardial
infarction in the elderly. Circulation 1999; 100 (Supplement I) I-805.
Rathore SF, Weinfurt KP, Schulman KA, Oetgen WJ, Gersh BJ, Solomon AJ. Acute myocardial
infarction complicated by advanced heart block in the elderly: patient characteristics and outcomes.
Circulation 1999; 100 (Supplement I) I-806.
Oetgen WJ, Snow PB, Brandt JM. Utilization of an artificial neural network for mortality risk
adjustment in the Cooperative Cardiovascular Project. Journal of the American College of
Cardiology 1999; 33 (Supplement A): 6A.
Oetgen WJ, Berger AK, Edris DW, Lesher MI, Jones J, Schuster M, Karge G, Breall JA, Fitzgerald
M, Molinari GF. Improvement in treatment quality indicators for elderly patients with acute
myocardial infarction: the Cooperative Cardiovascular Project in Maryland and the District of
Columbia. Journal of the American College of Cardiology 1999; 33 (Supplement A): 266A.
Rathore SS, Weinfurt KP, Oetgen WJ, Gersh BJ, Schulman KA. Refusal of catheterization during
acute myocardial infarction: influence of patient characteristics. Journal of the American College of
Cardiology1999; 33 (Supplement A): 356A.
William J. Oetgen, Jr., M.D., M.B.A.
Page 13
Thiemann DR, Coresh J, Oetgen WJ, Powe NR. The association between long-term survival and
hospital-specific rates of coronary angiography and revascularization after acute myocardial
infarction in the elderly. Journal of the American College of Cardiology 1999; 33 (Supplement A):
307A.
Rathore SS, Berger AK, Tracy CM, Oetgen WJ, Schulman KA, Gersh BJ, Solomon AJ: Acute
myocardial infarction complicated by atrial fibrillation in the elderly: patient characteristics and
outcomes. Circulation 1998; 98: I-629.
Rathore SS, Berger AK, Oetgen WJ, Gersh BJ, Schulman KA. Predictors of transfer during care
for acute myocardial infarction. Journal of General Internal Medicine 1998;13 (1): 47.
Rathore SS, Berger AK, Oetgen WJ, Gersh BJ, Schulman KA. Care and outcomes of patients
transferred for acute myocardial infarction treatment. Journal of General Internal Medicine 1998;
13 (1):19.
Johnson AE, Zanger DR, Berger AK, Oetgen WJ, Gersh BJ, Schulman KA. Diabetic women:
severity of acute myocardial infarction, chosen courses of therapy and health outcomes. Circulation
1997; 96 (October): I-764.
Berger AK, Johnson AE, Breall JA, Oetgen WJ, Marciniak TA, Gersh BJ, Schulman KA: The
effect of diabetes on mortality in Medicare beneficiaries with acute myocardial infarction.
Circulation 1997; 96(October): I-203.
Thiemann DR, Oetgen WJ, Powe NR: Acute MI patients admitted directly to cardiac centers have
lower long-term mortality: a HCFA Cooperative Cardiovascular Project study. Circulation 1997;
96(October): I-562.
Berger AK, Breall JA, Johnson AE, Schulman KA, Oetgen WJ, Pirzada SR, Frederick PR, Every
NR: Primary angioplasty vs. thrombolytic therapy in the elderly: the CCP experience. Circulation
1997; 96(October): I-595.
Itchhaporia D, Almassy RJ, Kaufman LV, Snow P, Oetgen WJ: Artificial neural network in the
noninvasive diagnosis of coronary artery disease. J Am Coll Cardiol Special Issue
1995;(February):328A.
Pettyjohn FS, Osborne RG, Oetgen WJ, Mitchell RE, Lilienthal MG: New electrocardiographic
criteria for left ventricular hypertrophy - application in aviation medicine. Aviat Space and Envir
Med 1986;57:489.
Tibbits PA, Perry LW, Birnbaum SF, Oetgen WJ, Hamilton K, Bocuzzi SJ: Prevalence of patent
ductus in critically ill neonates. Clinical Research 1985;53:233A.
Shuck JS, Oetgen, WJ, Tesar JT: Pulmonary vasospasm and response to nifedipine in progressive
sys-temic sclerosis. Arthritis and Rheumatism 1983;26:S63.
Oetgen WJ, Tibbits PA, Abt ME, Goldstein RE: Exacerbation of ventricular tachycardia associated
with oral flecainide acetate therapy. Clinical Research 1983;31:2l0A.
William J. Oetgen, Jr., M.D., M.B.A.
Page 14
Oetgen WJ, Sobol SM, Tri TB, Heydorn WH, Davia JE: Amiodarone-digoxin interaction: clinical
and experimental observations. Circulation 1982;66:II-382.
Oetgen WJ, Boice JA, Lawless OJ: Mixed Connective tissue disease in children and adolescent.
Year Book of Pediatrics, Yearbook Medical Publishers, Chicago, 1982, p. 336-7.
Mutter ML, Smallridge RC, Oetgen WJ, Rajfer SI, Kaminsky RJ, Schaff M: Radionuclide
cineangiographic evaluation of left ventricular function in acromegaly. Clinical Research,
1980;28:l98.
Oetgen WJ, Rajfer SI, Rocchini AP: Thallium 20l scintigraphy in patients after surgical repair of
coronary artery anomalies. Circulation 1979;60:II-9.
Oetgen WJ: Pertussoid eosinophilic pneumonia. Year Book of Diagnostic Radiology, l978. W.M.
Whithouse, ed. Yearbook Medical Publishers, Chicago, l978, p.395.
Oetgen WJ, Evans R, Landes RD: Hematologic and immunologic studies of toxic erythema of the
newborn. Society for Pediatric Research. Pediat Res 1976;10:379.
Oetgen WJ, Figelman AR: Continuous infusion of low dose insulin in the treatment of juvenile
diabetic ketoacidosis. American Pediatric Society. Pediat Res 1976;10:4l3.
Oetgen WJ, Ahr D: The coagulopathy of Reye's syndrome. in Reye's Syndrome, J.D. Pollack, ed,
Grune and Stratton, New York, l975, p.408.
Oetgen PM, DeCastro FJ, Oetgen WJ: Social Work and the adolescent: an attitudinal study.
Proceedings: Ambulatory Pediatric Association, May l973.
Oetgen WJ, DeCastro FJ, Rolfe UT, Richards SJ: A double-blind study of the use of flavoxate in
the treatment of nocturnal enuresis of childhood. Proceedings: Ambulatory Pediatric Association,
May l973.
Presentations at National and Regional Meetings
Oetgen WJ. Disease management and medical specialty societies. Disease Management
Colloquium, May 2006.
Wright, JS, Oetgen WJ, Fitzgerald ME, Thomas, SA, Hagan, EP. Medicare Health Support and the
American College of Cardiology. U.S. Department of HHS, Prevention Summit, (poster) October
2005.
Rodgers RL, Wagner, LK, Oetgen WJ, Thoumaian, AH. The quality assurance functions in
Medicare’s Lifestyle Modification Program Demonstration for coronary artery disease. U.S.
Department of HHS Steps to a Healthier US Summit, April 2004.
Wright C, Tanner W, Haft HM, Oetgen WJ. Turning the tide: a model for delivering diabetes selfmanagement and type 2 prevention education to the nation. U.S. Department of HHS Steps to a
Healthier US Summit, April 2004.
William J. Oetgen, Jr., M.D., M.B.A.
Page 15
Rathore SS, Gersh BJ, Oetgen WJ, Solomon AJ. Prognostic significance of conduction disorders
complicating acute myocardial infarction in the elderly. American College of Cardiology, March,
2001.
Rathore SS, Gersh BJ, Weinfurt KP, Oetgen WJ, Schulman KA, Solomon AJ. Effectiveness of
reperfusion therapy among elderly myocardial infarction patients presenting with left bundle branch
block. American Heart Association, November 2000.
Rathore SS, Epstein AJ, Weinfurt KP, Berger AK, Oetgen WJ, Gersh BJ, Schulman KA. Hospital
characteristics and treatment of acute myocardial infarction: role of ownership and teaching status.
American College of Cardiology, March 2000.
Rathore SS, Weinfurt KP, Gersh BJ, Oetgen WJ, Schulman KA, Solomon AJ. Treatment of paced
patients with acute myocardial infarction. American College of Cardiology, March 2000.
Rathore SS, Weinfurt KP, Gersh BJ, Oetgen WJ, Schulman KA, Solomon AJ. Reperfusion therapy
among paced patients with acute myocardial infarction. American College of Cardiology, March
2000.
Oetgen WJ. Quality improvement programs: the national perspective. Peer Review Organization of
New Jersey. January 2000.
Oetgen WJ. The Federal Government and Medical Quality Assurance. Northern Virginia Chapter,
American Association for Medical Transcription. January 2000.
Sheifer SE, Rathore SS, Gersh BJ, Weinfurt KP, Oetgen WJ, Breall JA, Schulman KA. Time to
presentation with acute myocardial infarction in the elderly: associations with race, gender and
poverty. American Heart Association, November 1999.
Rathore SF, Berger AK, Weinfurt KP, Feinleib M, Oetgen WJ, Gersh BJ, Schulman KA. Race,
gender, community socioeconomic characteristics and the medical treatment of acute myocardial
infarction in the elderly. American Heart Association, November 1999.
Rathore SF, Weinfurt KP, Schulman KA, Oetgen WJ, Gersh BJ, Solomon AJ. Acute myocardial
infarction complicated by advanced heart block in the elderly: patient characteristics and outcomes.
American Heart Association, November 1999.
Oetgen WJ. The Cooperative Cardiovascular Project in Maryland and DC: health care quality
improvement in the 1990s. Medical Grand Rounds, Georgetown University Medical Center, July
15, 1999.
Oetgen WJ, Stepowany ME, Bernstein A, Law WR. Partners in excellence discuss working
together. Maryland Campaign for Medicare Excellence Conference. Delmarva Foundation for
Medical Care, Inc. Health Care Financing Administration, Baltimore, Maryland, May 5, 1999.
Oetgen WJ, Snow PB, Brandt JM. Utilization of an artificial neural network for mortality risk
adjustment in the Cooperative Cardiovascular Project. American College of Cardiology, March
1999.
William J. Oetgen, Jr., M.D., M.B.A.
Page 16
Oetgen WJ, Berger AK, Edris DW, Lesher MI, Jones J, Schuster M, Karge G, Breall JA, Fitzgerald
M, Molinari GF. Improvement in treatment quality indicators for elderly patients with acute
myocardial infarction: the Cooperative Cardiovascular Project in Maryland and the District of
Columbia. American College of Cardiology, March 1999.
Rathore SS, Weinfurt KP, Oetgen WJ, Gersh BJ, Schulman KA. Refusal of catheterization during
acute myocardial infarction: influence of patient characteristics. American College of Cardiology,
March 1999.
Thiemann DR, Coresh J, Oetgen WJ, Powe NR. The association between long-term survival and
hospital-specific rates of coronary angiography and revascularization after acute myocardial
infarction in the elderly. American College of Cardiology, March 1999.
Rathore SS, Berger AK, Tracy CM, Oetgen WJ, Schulman KA, Gersh BJ, Solomon AJ: Acute
myocardial infarction complicated by atrial fibrillation in the elderly: patient characteristics and
outcomes. American Heart Association, November 1998.
Rathore SS, Berger AK, Oetgen WJ, Gersh BJ, Schulman KA. Predictors of transfer during care
for acute myocardial infarction. Society of General Internal Medicine, April 1998.
Rathore SS, Berger AK, Oetgen WJ, Gersh BJ, Schulman KA. Care and outcomes of patients
transferred for acute myocardial infarction treatment. Society of General Internal Medicine, April
1998.
Johnson AE, Zanger DR, Berger AK, Oetgen WJ, Gersh BJ, Schulman KA. Diabetic women:
severity of acute myocardial infarction, chosen courses of therapy and health outcomes. National
Heart Lung and Blood Institute Research Meeting, February 1998.
Rathore SS, Johnson AE, Berger AK, Oetgen WJ, Gersh BJ, Schulman KA. Predictors of
discharge to home following treatment for acute myocardial infarction. National Heart Lung and
Blood Institute Research Meeting, February 1998.
Johnson AE, Zanger DR, Berger AK, Oetgen WJ, Gersh BJ, Schulman KA. Diabetic women:
severity of acute myocardial infarction, chosen courses of therapy and health outcomes. American
Heart Association, November 1997.
Berger AK, Breall JA, Johnson AE, Schulman KA, Oetgen WJ, Pirzada SR, Frederick PR, Every
NR: Primary angioplasty vs. thrombolytic therapy in the elderly: the CCP experience. American
Heart Association, November 1997.
Berger AK, Johnson AE, Breall JA, Oetgen WJ, Marciniak TA, Gersh BJ, Schulman KA: The
effect of diabetes on mortality in Medicare beneficiaries with acute myocardial infarction.
American Heart Association, November 1997.
Thiemann DR, Oetgen WJ, Powe NR: Acute MI patients admitted directly to cardiac centers have
lower long-term mortality: a HCFA Cooperative Cardiovascular Project study. American Heart
Association, November 1997.
William J. Oetgen, Jr., M.D., M.B.A.
Page 17
Berger AK, Breall JA, Johnson AE, Schulman KA, Oetgen WJ, Pazada SR, Frederick PD, Every
NR: Primary angioplasty vs. thrombolytic therapy in the elderly: the CCP experience. American
Heart Association, November 1997.
Oetgen WJ: Cooperative Cardiovascular Project: soliciting hospital action plans. HCFA
Cooperative Cardiovascular Project Liaison Conference, (poster) November, 1997.
Oetgen WJ: Cooperative Cardiovascular Project: strategies for soliciting action plans and a
preliminary report on improvement strategies. American Health Quality Association, January, 1997.
Oetgen WJ: HMOs as future payers. Southern Maryland Health Plan Seminar on the Future of
Physicians and Hospital Medicine, September, 1996.
Oetgen WJ: Topics in Aviation Medicine. Helicopter Flight Instructor Seminar, American
Eurocopter Company, September, 1996.
Breall JA, Oetgen WJ: A right heart catheterization quality improvement project. Boston Regional
Office, Health Care Financing Administration, Peer Review Organization Forum, August, 1996.
Itchhaporia D, Almassy RJ, Kaufman LV, Snow P, WJ: Artificial neural network in the
noninvasive diagnosis of coronary artery disease. American College of Cardiology, (poster), March,
1995.
Pettyjohn FS, Osborne RG, Oetgen WJ, Mitchell RE, Lilienthal MG: New electrocardiographic
criteria for left ventricular hypertrophy - application in aviation medicine. Aerospace Medical
Association, April, 1986.
Tibbits PA, Perry LW, Birnbaum SF, Oetgen WJ, Hamilton K, Bocuzzi SJ: Prevalence of patent
ductus in critically ill neonates. American Federation for Clinical Research, April, l985.
Shuck JW, Oetgen WJ, Tesar JT: Pulmonary vasospasm and response to nifedipine in progressive
systemic sclerosis. American Rheumatism Association, (poster) June l983.
Oetgen WJ, Pettyjohn FS: Intracardiac electrophysiologic studies in the medical evaluation of
aviators. Aerospace Medical Association, May, l983.
Zoltick J, Oetgen WJ, Patton J, Daniels W, Vogel J, Bedynek J, Davia JE: Cardiovascular screening
evaluation for coronary artery disease in asymptomatic aviators over age forty. Aerospace Medical
Association, May l983.
Pettyjohn FS, Oetgen WJ, Kellogg GF, Lilienthal MG: Congenital bicuspid aortic valve aeromedical considerations. Aerospace Medical Association, May l983.
Oetgen WJ, Tibbits PA, Abt ME, Goldstein RE: Exacerbation of ventricular tachyarrhythmias
associated with oral flecainide acetate therapy. American Federation of Clinical Research, (poster)
April l983.
William J. Oetgen, Jr., M.D., M.B.A.
Page 18
Oetgen, WJ, Sobol SM, Tri TB, Heydorn WH, Davia JE, Rakita L: Amiodarone-digoxin
interaction: clinical and experimental observations. American Heart Association (poster) November
l982.
Oetgen WJ, Mutter ML, Lawless OJ, Davia JE: Cardiac abnormalities in mixed connective tissue
disease. American Arthritis Association (poster) June l98l.
Oetgen WJ: Electrocardiography for flight surgeons. Aerospace Medical Association, May l980.
Brewer TG, Oetgen WJ: Hepatitis in the military: implications for the private practitioner.
Southern Medical Association, November l979.
Oetgen WJ, Rajfer SI, Rocchini AP: Thallium-20l scintigraphy in patients after surgical repair of
coronary artery anomalies. American Heart Association, October l979.
Oetgen WJ, Landes RD: Aeromedical evacuation of high risk infants in the military medical
system. American Academy of Pediatrics, October l976.
Oetgen WJ: A review of Reye's Syndrome. American Academy of Pediatrics, October l975.
Oetgen WJ: The use of citrulline in the treatment of Reye's Syndrome. American Academy of
Pediatrics, October l975.
Oetgen WJ, Pepper MP: Medical school admissions committees. Conference on Research in
Medical Education, Association of American Medical Colleges, November l97l.
Clinical Trials
Oetgen WJ, Haft HM. A double-blind, placebo-controlled randomized clinical trial of slow release
Propafenone (Rhythmol®-SR) in the prevention of symptomatic recurrences of atrial fibrillation.
Knoll Pharmaceutical Company. Maryland HealthCare Associates, L.L.C., 1999-2000.
Oetgen WJ, Haft HM. A study to evaluate the effect of lansoprazole 30 mg QD versus omeprazole
20 mg QD on relief of symptoms in patients with erosive reflux esophagitis. Phoenix International
Life Sciences. Maryland HealthCare Associates, L.L.C., 1999-2000.
Oetgen WJ: Renal function survey after intravascular radiocontrast procedure in patients with
baseline serum creatinine > 1.3 mg/dl. Rx Trials, Inc., Maryland HealthCare Associates, L.L.C.,
1998.
Oetgen WJ, Tanner WT. A randomized, double-blind multicenter, comparative phase III study of
gatifloxacin versus ceftriaxone in the treatment of community-acquired pneumonia requiring
hospitalization. Bristol-Myers Squibb Pharmaceutical Research Institute. Maryland HealthCare
Associates, L.L.C., 1997-1998.
William J. Oetgen, Jr., M.D., M.B.A.
Page 19
The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on
mortality and reinfarction after myocardial infarction. Walter Reed Army Medical Center, 1983 1985.
Oetgen, WJ. Amiodarone open label, compassionate use for significant ventricular arrhythmias.
Walter Reed Army Medical Center, Washington DC, 1981-1986.
Oetgen WJ, Tibbits PA, Goldstein RE. Oral flecainide open label use for significant ventricular
arrhythmias. Walter Reed Army Medical Center, Washington DC, 1981-1983.
Shuck JW, Oetgen WJ, Tesar JT: Oral nifedipine for the treatment of pulmonary vasospasm in
progressive systemic sclerosis. Walter Reed Army Medical Center, Washington DC, 1981-1982.
cv-wjo.doc